• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Brain Oxygen Extraction Fraction Studies Show Inconsistent Patterns in Alzheimer’s Disease

by
November 11, 2026
in Health
Reading Time: 3 mins read
0
Brain Oxygen Extraction Fraction Studies Show Inconsistent Patterns in Alzheimer's Disease

Brain Oxygen Extraction Fraction Studies Show Inconsistent Patterns in Alzheimer's Disease

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A scoping review investigating magnetic resonance imaging assessments of cerebral oxygen extraction fraction has found that measured changes in brain aging and Alzheimer’s disease remain inconsistent across research investigations and imaging methodologies. While oxygen extraction fraction represents the cerebral balance between oxygen delivery and oxygen consumption, making it a prominent candidate biomarker for cerebral metabolism, the synthesised observational literature does not currently demonstrate a uniform direction or regional pattern of change. Consequently, the authors determined that available evidence does not yet support biomarker-level claims for oxygen extraction fraction in clinical or diagnostic contexts.

Published in BMC Neurology, the review mapped and evaluated oxygen extraction fraction as a research biomarker across published literature covering January 2014 through September 2026. In biological terms, oxygen extraction fraction reflects how the brain balances metabolic consumption with vascular delivery. In healthy aging and Alzheimer’s disease, including its prodromal stage of mild cognitive impairment, researchers monitor this metric to obtain insight into pathophysiological shifts that may relate to cognitive and functional outcomes. However, methodological variation across the field has complicated efforts to establish whether oxygen extraction increases, decreases, or remains stable as neurodegeneration develops.

The investigators adopted a scoping review framework governed by the PRISMA extension for Scoping Reviews guidelines rather than a conventional systematic review structure. Because the core research question was broad by design, eligibility criteria were refined iteratively as evidence emerged rather than being fixed a priori, and prospective protocol registration was not required or performed. A comprehensive literature search conducted across six electronic databases—PubMed, Google Scholar, ProQuest, IEEE Xplore, ScienceDirect, and MEDLINE—initially retrieved 1,364 records. Following the removal of 131 duplicate entries and subsequent screening, 21 studies met eligibility criteria, with 16 studies forming the core synthesis on brain aging, mild cognitive impairment, and Alzheimer’s disease. Other neurological conditions captured incidentally by the database search, including multiple sclerosis, normal pressure hydrocephalus, sickle-cell disease, and RVCL-S, fell outside the primary scope and were addressed only narratively.

The primary evidence base comprised 12 human observational studies and four preclinical animal investigations. Quality and risk of bias were systematically evaluated using the Newcastle-Ottawa Scale for the human observational cohorts and the SYRCLE risk-of-bias assessment tool for the preclinical animal experiments. Methodological heterogeneity across imaging platforms, measured brain regions, and analytical pipelines proved substantial, precluding the authors from executing a pooled quantitative meta-analysis. Instead, the authors conducted a qualitative synthesis of the contrasting findings reported across the different experimental approaches.

Across the reviewed studies, reported directions of oxygen extraction fraction alterations diverged markedly according to the specific imaging techniques deployed. Several investigations reported reductions in oxygen extraction fraction, particularly when employing tissue-based imaging techniques in cohorts with Alzheimer’s disease. Conversely, other studies identified age-related increases in oxygen extraction fraction, particularly when utilising venous-targeted methodologies such as TRUST and AS-aTRUPC. Adding further complexity, a third group of studies documented no statistically significant differences in oxygen extraction fraction between groups, even while recording distinct, measurable reductions in cerebral blood flow and the cerebral metabolic rate of oxygen.

Where multi-modal imaging sequences were applied, researchers observed that regional alterations in oxygen extraction fraction were linked to microvascular pathology, including the presence and distribution of white matter hyperintensities.

The authors concluded that while oxygen extraction fraction remains a biologically motivated candidate metric for examining cerebral oxygen metabolism, its directional relationship with aging and Alzheimer’s pathology is not established. Only a single included study incorporated a longitudinal design, and none evaluated interventional protocols. Given these structural limitations, rigorous methodological standardisation and dedicated longitudinal validation studies are required before the research and clinical utility of oxygen extraction fraction can be reliably determined.

Future progress will depend on resolving the three primary sources of methodological divergence identified by the authors: variations in imaging modality, targeted brain region, and analytical pipeline. Until harmonized protocols and prospective longitudinal investigations establish the true trajectory of cerebral oxygen metabolism, oxygen extraction fraction will remain a biologically motivated candidate metric rather than an established biomarker for clinical utility.

Subject of Research: MRI-based oxygen extraction fraction in brain aging and Alzheimer's disease

Article Title: Measuring oxygen extraction fraction (OEF) in brain aging and AD: a scoping review of observational studies

Article References: Ghasemishayan, R., Sajjadian, F., Molazadeh, M., Khani, M., & Mortezazadeh, T. (2026). Measuring oxygen extraction fraction (OEF) in brain aging and AD: a scoping review of observational studies. BMC Neurology. https://doi.org/10.1186/s12883-026-05555-4

Image Credits: AI Generated

DOI: 10.1186/s12883-026-05555-4

Keywords: oxygen extraction fraction, OEF, brain aging, Alzheimer's disease, mild cognitive impairment, scoping review, magnetic resonance imaging, cerebral blood flow, cerebral metabolic rate of oxygen, TRUST, AS-aTRUPC, white matter hyperintensities, microvascular pathology, PRISMA-ScR, Newcastle-Ottawa Scale, SYRCLE risk-of-bias, observational studies, preclinical studies

News Source: Cassandra Pierce. (November 11, 2026). Brain Oxygen Extraction Fraction Studies Show Inconsistent Patterns in Alzheimer’s Disease. Scienmag.

Tags: Alzheimer's diseaseAS-aTRUPCBrain agingcerebral blood flowcerebral metabolic rate of oxygenmagnetic resonance imagingmicrovascular pathologymild cognitive impairmentNewcastle-Ottawa Scaleobservational studiesOEFoxygen extraction fractionpreclinical studiesPRISMA-ScRscoping reviewSYRCLE risk of biastrustwhite matter hyperintensities
Share12Tweet7Share2ShareShareShare1

Related Posts

Sphingomyelins Inversely Associate with Atherogenic sdLDL Particle Ratio in Cross-Sectional Study

Sphingomyelins Inversely Associate with Atherogenic sdLDL Particle Ratio in Cross-Sectional Study

November 19, 2026
Dual Normal CA19-9 and DUPAN-2 Predicts Improved Survival in Pancreatic Cancer

Dual Normal CA19-9 and DUPAN-2 Predicts Improved Survival in Pancreatic Cancer

November 19, 2026

Heat and Humidity Challenge Endurance Athletes as Researchers Propose Standardised Testing

November 19, 2026

Psoriasis Mimic Diagnosed as Pemphigus Foliaceus via Detailed Tissue Pathology

November 19, 2026

POPULAR NEWS

  • Lifelong Social Isolation Tied to Muscle Weakness but Lower Obesity Odds

    Lifelong Social Isolation Tied to Muscle Weakness but Lower Obesity Odds

    29 shares
    Share 12 Tweet 7
  • Narrative Review Identifies Systematic Bias and Privacy Risks Across AI Electrocardiography Protocols

    29 shares
    Share 12 Tweet 7
  • Landscape Integrated Farming Framework Links Cross-Farm Resources to Enhance Climate Resilience

    29 shares
    Share 12 Tweet 7
  • Machine Learning Matches Traditional Time Series in Forecasting Tanzanian Sisal Exports

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sphingomyelins Inversely Associate with Atherogenic sdLDL Particle Ratio in Cross-Sectional Study

Review Assesses Zanubrutinib Across Clinical Trials in Chronic Lymphocytic Leukemia

Dual Normal CA19-9 and DUPAN-2 Predicts Improved Survival in Pancreatic Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.